Meta-analysis: Fact or fiction? How to interpret meta-analyses

World Journal of Biological Psychiatry

Volumn 12, Issue 3, 2011, Pages 188-200

  Huf, Wolfgang ^a,b,c   Kalcher, Klaudius ^a,b,c   Pail, Gerald ^a   Friedrich, Michaela Elena ^a   Filzmoser, Peter ^c   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

^c VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

antidepressants; Depression; interpretation; major depressive disorder; metaanalysis

Indexed keywords

ARTICLE; DATA ANALYSIS; MAJOR DEPRESSION; META ANALYSIS (TOPIC); METHODOLOGY; MOOD DISORDER; SAMPLE SIZE; STATISTICAL MODEL;

ANTIDEPRESSIVE AGENTS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; PUBLICATION BIAS; RESEARCH DESIGN; SCIENTIFIC MISCONDUCT;

EID: 79954446291     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.551544     Document Type: Article

References (53)

1. Ades AE, Lu G, Higgins JPT. 2005. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 25:646-654. (Pubitemid 41667133)
2. Bandelow B, Zohar J, Kasper S, Möller HJ. 2008. How to grade categories of evidence. World J Biol Psychiatry 9:242-247.
3. Bennett DA. 2001. How can I deal with missing data in my study? Aust NZ J Public Health 25:464-469. (Pubitemid 32952052)
4. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, et al. 2009. Comparative effi cacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746-758.
5. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale. Lawrence Erlbaum Associates, Inc.
6. Duval S, Tweedie R. 2000. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-463. (Pubitemid 30422636)
7. Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634. (Pubitemid 27387172)
8. Fountoulakis KN, M ö ller HJ. 2010. Efficacy of antidepressants: a re-analysis and reinterpretation of the Kirsch data. Int J Neuropsychopharmacol 1-8.
9. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. 2010. Antidepressant drug effects and depression severity: a patient-level metaanalysis. J Am Med Assoc 303:47-53.
10. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. 2006. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59:7-10. (Pubitemid 41797469)
11. Garg AX, Hackam D, Tonelli M. 2008. Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3:253-260.
12. Geddes JR, Calabrese JR, Goodwin GM. 2009. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4-9.
13. Gelfand LA, Strunk DR, Tu XM, Noble RES, Derubeis RJ. 2006. Bias resulting from the use of ' assay sensitivity ' as an inclusion criterion for meta-analysis. Stat Med 25:943-955. (Pubitemid 43337982)
14. Hammad TA, Laughren T, Racoosin J. 2006. Suicidality in pedi-atric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332-339. (Pubitemid 43345358)
15. Hansen RA, Moore CG, Dusetzina SB, Leinwand BI, Gartlehner G, Gaynes BN. 2009. Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antide-pressant dose. Med Decis Making 29:91-103.
16. Harbord RM, Whiting P, Sterne JAC, Egger M, Deeks JJ, Shang A, et al. 2008. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol 61:1095-1103.
17. Hardy RJ, Thompson SG. 1998. Detecting and describing heterogeneity in meta-analysis. Stat Med 17:841-856. (Pubitemid 28185164)
18. Hedges LV, Pigott TD. 2001. The power of statistical tests in meta-analysis. Psychol Methods 6:203-217. (Pubitemid 33600378)
19. Hedges LV, Pigott TD. 2004. The power of statistical tests for moderators in metaanalysis. Psychol Methods 9:426-445. (Pubitemid 40005041)
20. Higgins J, Green S, editors, 2009. Cochrane handbook for systematic reviews of interventions, version 5.0.2. The Cochrane Collaboration.
21. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. Br Med J 327:557-560. (Pubitemid 37088507)
22. Higgins JPT, White IR, Wood AM. 2008. Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials 5:225-239.
23. Horder J, Matthews P, Waldmann R. 2010. Placebo, prozac and plos: signifi cant lessons for psychopharmacology. J Psychopharmacol.
24. Ioannidis JPA. 2005. Why most published research findings are false. PLoS Med 2:e124.
25. Jackson D. 2006. The power of the standard test for the presence of heterogeneity in meta-analysis. Stat Med 25: 2688-2699. (Pubitemid 44082455)
26. Jüni P, Witschi A, Bloch R, Egger M. 1999. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 282:1054-1060. (Pubitemid 29436453)
27. Kasper S. 2010. The proof of effi cacy in psychopharmacology: clinical studies, metaanalysis and evidence-based medicine. Eur Arch Psychiatry Clin Neurosci 260:1.
28. Khan A, Leventhal RM, Khan SR, Brown WA. 2002. Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database. J Clin Psychopharmacol 22:40-45. (Pubitemid 34101291)
29. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson B T. 2008. Initial severity and antidepressant benefi ts: a meta-analysis of data submitted to the food and drug administration. PLoS Med 5:e45.
30. Lambert PC, Sutton AJ, Abrams KR, Jones DR. 2002. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 55: 86-94. (Pubitemid 34037039)
31. Lee WL, Bausell RB, Berman BM. 2001. The growth of health-related meta-analyses published from 1980 to 2000. Eval Health Prof 24:327-335. (Pubitemid 33089762)
32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, G ø tzsche PC, Ioannidis JPA, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100.
33. Maier W, M ö ller HJ. 2010. Meta-analyses: a method to maximise the evidence from clinical studies? Eur Arch Psychiatry Clin Neurosci 260:17-23.
34. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. 2003. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. Br Med J 326:1171-1173. (Pubitemid 36649049)
35. Melander H, Salmonson T, Abadie E, van Zwieten-Boot B. 2008. A regulatory apologia - a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol 18:623-627.
36. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. 1999. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. quality of reporting of meta-analyses. Lancet 354:1896-1900.
37. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097.
38. Möller HJ, Broich K. 2010. Principle standards and problems regarding proof of effi cacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci 260:3-16.
39. Möller HJ, Maier W. 2010. Evidence-based medicine in psychop-harmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:25-39.
40. Patsopoulos NA, Analatos AA, Ioannidis JPA. 2005. Relative citation impact of various study designs in the health sciences. J Am Med Assoc 293:2362-2366. (Pubitemid 40676758)
41. Pearson K. 1904. Report on certain enteric fever inoculation statistics. Br Med J 3:1243-1246.
42. Petticrew M. 2001. Systematic reviews from astronomy to zoology: myths and misconceptions. Br Med J 322:98-101. (Pubitemid 32099148)
43. Robertson C, Idris NRN, Boyle P. 2004. Beyond classical meta-analysis: can inadequately reported studies be included? Drug Discov Today 9:924-931. (Pubitemid 39389053)
44. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. 2008. Design makes a difference: a meta-analysis of antidepressant response rates in placebocontrolled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 16:65-73.
45. Stewart LA, Tierney JF. 2002. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 25:76-97. (Pubitemid 34157785)
46. Sutton AJ, Higgins JPT. 2008. Recent developments in meta-analysis. Stat Med 27:625-650. (Pubitemid 351278810)
47. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. 2006. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 63:1217-1223. (Pubitemid 44708080)
48. Terrin N, Schmid CH, Lau J, Olkin I. 2003. Adjusting for publication bias in the presence of heterogeneity. Stat Med 22: 2113-2126. (Pubitemid 36818038)
49. Thompson SG. 1994. Why sources of heterogeneity in meta-analysis should be investigated. Br Med J 309:1351-1355. (Pubitemid 24345976)
50. Thompson SG, Higgins JPT. 2002. How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573. (Pubitemid 34746063)
51. Tritchler D. 1999. Modelling study quality in meta-analysis. Stat Med 18:2135-2145. (Pubitemid 29408256)
52. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. 2008. Selective publication of antide-pressant trials and its infl uence on apparent effi cacy. New Engl J Med 358:252-260.
53. Walsh BT, Seidman SN, Sysko R, Gould M. 2002. Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 287:1840-1847. (Pubitemid 34303629)